NCT00260156View on ClinicalTrials.gov

A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

DRUG

placebo

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY